Mayo Clinic: A new type of defibrillator met safety, effectiveness goals in global clinical study
August 31, 2022
August 31, 2022
ROCHESTER, Minnesota, Aug. 31 (TNSjou) -- The Mayo Clinic issued the following news release:
A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and effectiveness goals for participants in a premarket global clinical study. The device effectively terminated acute and chronic life-threatening ventricular arrhythmias. The findings were presented during a late-breaking session at the European Society of . . .
A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and effectiveness goals for participants in a premarket global clinical study. The device effectively terminated acute and chronic life-threatening ventricular arrhythmias. The findings were presented during a late-breaking session at the European Society of . . .